Search - tctmd.com

Displaying 301 - 320 of 323

Sort: Relevancy | Date

Presentation ACC 2012

Renal Sympathetic Denervation for Treatment of Resistant Hypertension: One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial

Presenter: Murray Esler

March 25, 2012

Presentation

EVAR with Carbon Dioxide-Guided Angiography in Patients with Renal Insufficiency

Presenter: Enrique Criado

March 07, 2012

Presentation

EVAR mediante Angiografía con Dióxido de Carbono en Pacientes con Insuficiencia Renal

Presenter: E. Criado

March 07, 2012

Presentation

Renal Sympathetic Denervation Reduces LV Hypertrophy and Improves Cardiac Function in Patients with Resistant Hypertension

Presenter: M. Brandt

February 26, 2012

Presentation

La Denervación Simpática Renal Reduce la Hipertrofia VI y Mejora la Función Cardíaca en Pacientes que padecen Hipertensión Resistente

Presenter: M. Brandt

February 26, 2012

Presentation

Sodium Chloride vs. Sodium Bicarbonate for the Prevention of Contrast Induced Nephropathy (CIN)

Presenter: T. Klima

January 23, 2012

Presentation

Prevention of Contrast Nephropathy by Furosemide with Matched Hydration

Presenter: Giancarlo Marenzi

January 17, 2012

Presentation ISET 2012

Will Renal Denervation and Other Interventions Be the Next Great Opportunity in Endovascular Therapy?

Presenter: Horst Sievert

January 15, 2012

Presentation TCT 2012

Use Of Paclitaxel-Eluting Stents Reduces Target Lesion Revascularization for Dialysis Patients.

Presenter: Hirotoshi Watanabe, Kyohei Yamaji, Yoshimitsu Soga, Shinichi Shirai, Kenji Ando, Koyu Sakai, Katsuhiro Kondo, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Masakiyo Nobuyoshi

January 03, 2012

Presentation TCT 2012

Tridimensional Rotational Angiography and Transplant Renal Artery Stenosis: 40 Cases Analysis.

Presenter: Erlon O. Silva, Rodrigo Souza, Alexandre V. Bonfim, Cristiano F. Souza, Adriano P. Barbosa, Claudia R. Alves, Jose O. Pestana, Valter C. Lima

January 03, 2012

Presentation TCT 2012

Relationship between SYNTAX Score and Contrast Induced Acute Kidney Injury in Patients with CKD undergoing Coronary Angiography or PCI

Presenter: Ayesha C. Qureshi, Roshan Weerackody, Muhiddin Ozkor, Magdi Yaqoob, Akhil Kapur

January 03, 2012

Presentation TCT 2012

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Presenter: Weon Kim, Won-Yu Kang, Jong-Shin Woo

January 03, 2012

Presentation TCT 2012

Invasive Treatment of Patients with Non-ST-Segment Elevation Myocardial Infarction and Severe Renal Dysfunction - Early and 12-month Outcomes from the PL-ACS Registry.

Presenter: Marek Gierlotka, Mariusz Gasior, Mateusz Tajstra, Piotr Rozentryt, Jacek Kowalczyk, Michal Hawranek, Marianna Janion, Andrzej Lekston, Marian Zembala, Lech Polonski

January 03, 2012

Presentation TCT 2012

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

Presenter: Giulio G. Stefanini, Bindu Kalesan, Lorenz Raber, Thomas Pilgrim, Yoshinobu Onuma, Sigmund Silber, Patrick W. Serruys, Bernhard Meier, Peter Juni, Stephan Windecker

January 03, 2012

Presentation TCT 2012

High Concentration Sodium Bicarbonate for the Prevention Of Contrast-induced Nephropathy.

Presenter: Nozomu Tamai, Shigenori Ito, Kosuke Nakasuka, Kazuyuki Miyata, Masahiko Inomata, Takayuki Yoshida, Shin Suzuki, Yoshimasa Murakami, Koichi Sato

January 03, 2012

Presentation TCT 2012

Effectiveness of Theophylline in Prevention of Contrast-Induced Nephropathy in Risky Egyptian Patients Undergoing Elective Coronary Angiography or Percutaneous Intervention: A...

Presenter: Mohammed Elshawadfy, Mohammed A. Oraby, Hussein M. Ismail, Fathi A. Maklady

January 03, 2012

Presentation TCT 2012

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Presenter: Joseph Kim, Helen Vlachos, Suresh R. Mulukutla, Catalin Toma, Joon S. Lee, David O. Williams, Sheryl F. Kelsey, Kevin E. Kip, Oscar C. Marroquin

January 03, 2012

Presentation TCT 2012

Cystatin C is superior diagnostic tool compared with conventional Serum Creatinine or Estimated Glomerular Filtration Rate in prediction of Contrast Induced Nephropathy.

Presenter: Hyuck Jun Yoon, Ji Hyun Sohn, Hong Won Shin, Ho Myung Lee, Hyun ok Cho, Hyoung-Seob Park, Yun-Kyeong Cho, Chang-Wook Nam, Hyungseop Kim, Seung Ho Hur, Yoon-Nyun Kim, Kwon Bae Kim

January 03, 2012

Presentation TCT 2012

Contrast Induced Nephropathy in Patients With Normal Renal Function Undergoing Complex PCI with High Dose of Contrast Media : Predictive Value of Cystatin C

Presenter: Norbert Mayaud, Karl Isaaz, Christophe Mariat, Alexis Cerisier, Michel Lamaud, Laure Richard, Antoine Da Costa

January 03, 2012

Presentation TCT 2012

Clinical impact of renal function recovery after contrast induced nephropathy on long-term adverse event.

Presenter: Hyuck Jun Yoon, Ji Hyun Sohn, Ho Myung Lee, Hyun ok Cho, Hong Won Shin, Yun-Kyeong Cho, Hyoung-Seob Park, Hyungseop Kim, Chang-Wook Nam, Seung Ho Hur, Yoon-Nyun Kim, Kwon Bae Kim

January 03, 2012

Advertisement

Renal Sympathetic Denervation for Treatment of Resistant Hypertension: One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial

EVAR with Carbon Dioxide-Guided Angiography in Patients with Renal Insufficiency

EVAR mediante Angiografía con Dióxido de Carbono en Pacientes con Insuficiencia Renal

Renal Sympathetic Denervation Reduces LV Hypertrophy and Improves Cardiac Function in Patients with Resistant Hypertension

La Denervación Simpática Renal Reduce la Hipertrofia VI y Mejora la Función Cardíaca en Pacientes que padecen Hipertensión Resistente

Sodium Chloride vs. Sodium Bicarbonate for the Prevention of Contrast Induced Nephropathy (CIN)

Prevention of Contrast Nephropathy by Furosemide with Matched Hydration

Will Renal Denervation and Other Interventions Be the Next Great Opportunity in Endovascular Therapy?

Use Of Paclitaxel-Eluting Stents Reduces Target Lesion Revascularization for Dialysis Patients.

Tridimensional Rotational Angiography and Transplant Renal Artery Stenosis: 40 Cases Analysis.

Relationship between SYNTAX Score and Contrast Induced Acute Kidney Injury in Patients with CKD undergoing Coronary Angiography or PCI

Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis.

Invasive Treatment of Patients with Non-ST-Segment Elevation Myocardial Infarction and Severe Renal Dysfunction - Early and 12-month Outcomes from the PL-ACS Registry.

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

High Concentration Sodium Bicarbonate for the Prevention Of Contrast-induced Nephropathy.

Effectiveness of Theophylline in Prevention of Contrast-Induced Nephropathy in Risky Egyptian Patients Undergoing Elective Coronary Angiography or Percutaneous Intervention: A...

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients with Chronic Kidney Disease: A Report From the National Heart, Lung, and Blood...

Cystatin C is superior diagnostic tool compared with conventional Serum Creatinine or Estimated Glomerular Filtration Rate in prediction of Contrast Induced Nephropathy.

Contrast Induced Nephropathy in Patients With Normal Renal Function Undergoing Complex PCI with High Dose of Contrast Media : Predictive Value of Cystatin C

Clinical impact of renal function recovery after contrast induced nephropathy on long-term adverse event.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content